103 related articles for article (PubMed ID: 11172829)
1. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs.
Hickey M; Higham J; Sullivan M; Miles L; Fraser IS
Fertil Steril; 2001 Feb; 75(2):288-96. PubMed ID: 11172829
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
Chegini N; Rhoton-Vlasak A; Williams RS
Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
[TBL] [Abstract][Full Text] [Related]
4. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Vincent AJ; Zhang J; Ostör A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2002 May; 17(5):1189-98. PubMed ID: 11980737
[TBL] [Abstract][Full Text] [Related]
5. Endometrial ablation for refractory postmenopausal bleeding with continuous hormone replacement therapy.
Spaulding LB
Fertil Steril; 1994 Dec; 62(6):1181-5. PubMed ID: 7957981
[TBL] [Abstract][Full Text] [Related]
6. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
7. Endometrial expression of steroid receptors in postmenopausal hormone replacement therapy users: relationship to bleeding patterns.
Vani S; Critchley HO; Fraser IS; Hickey M
J Fam Plann Reprod Health Care; 2008 Jan; 34(1):27-34. PubMed ID: 18201403
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding.
Nagele F; O'Connor H; Baskett TF; Davies A; Mohammed H; Magos AL
Fertil Steril; 1996 Jun; 65(6):1145-50. PubMed ID: 8641488
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
[TBL] [Abstract][Full Text] [Related]
10. Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels.
Hickey M; Doherty DA; Fraser IS; Sloboda DM; Salamonsen LA
Hum Reprod; 2008 Apr; 23(4):912-8. PubMed ID: 18216041
[TBL] [Abstract][Full Text] [Related]
11. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding.
Hickey M; Pillai G; Higham JM; Sullivan M; Horncastle D; Doherty D; Stamp G
Hum Reprod; 2003 May; 18(5):1100-6. PubMed ID: 12721191
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase enzymes in endometrium of women with abnormal uterine bleeding.
Grzechocinska B; Dabrowski FA; Chlebus M; Gondek A; Czarzasta K; Michalowski L; Cudnoch-Jedrzejewska A; Wielgos M
Neuro Endocrinol Lett; 2018 Feb; 38(8):537-543. PubMed ID: 29504731
[TBL] [Abstract][Full Text] [Related]
13. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
[TBL] [Abstract][Full Text] [Related]
14. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
[TBL] [Abstract][Full Text] [Related]
15. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.
Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M
Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646
[TBL] [Abstract][Full Text] [Related]
16. Disturbances of endometrial bleeding with hormone replacement therapy.
Thomas AM; Hickey M; Fraser IS
Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
[TBL] [Abstract][Full Text] [Related]
17. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules.
Ettinger B; Li DK; Klein R
Fertil Steril; 1998 May; 69(5):865-9. PubMed ID: 9591494
[TBL] [Abstract][Full Text] [Related]
18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
19. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
Yang JH; Wu MY; Chen MJ; Chen SU; Yang YS; Ho HN
Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810
[TBL] [Abstract][Full Text] [Related]
20. [Endometrial cytology in normal postmenopausal women and during hormone replacement therapy].
Wei Y; Xue J; Lin S
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):432-5. PubMed ID: 9639733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
